Cellular Therapies in Systemic Sclerosis: Recent Progress.

ABSTRACT: Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with a high mortality and morbidity. While progress has been made in terms of identifying high-risk patients and implementing new treatment strategies, therapeutic options remain limited. In the past few decades, various cellular therapies have emerged, which have been studied in SSc and other conditions. Here, we provide a comprehensive review of currently available cellular therapies and critically assess their merit as disease-modifying treatment for SSc. Currently, hematopoietic stem cell transplantation is the only cellular therapy that has demonstrated clinical effects on the immune system, neoangiogenesis, and fibrosis. Robust mechanistic studies as well as clinical trials are essential to move the field forward

SUBMITTER: van Rhijn-Brouwer FC 

PROVIDER: S-EPMC4779139 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature